Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Asset Writedowns and Impairment (2017 - 2023)

Historic Asset Writedowns and Impairment for Research Frontiers (REFR) over the last 5 years, with Q3 2023 value amounting to $100000.0.

  • Research Frontiers' Asset Writedowns and Impairment rose 210000.0% to $100000.0 in Q3 2023 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year change of. This contributed to the annual value of $25001.0 for FY2024, which is 7368.32% down from last year.
  • According to the latest figures from Q3 2023, Research Frontiers' Asset Writedowns and Impairment is $100000.0, which was up 210000.0% from -$5000.0 recorded in Q1 2023.
  • In the past 5 years, Research Frontiers' Asset Writedowns and Impairment ranged from a high of $133969.0 in Q4 2019 and a low of -$10000.0 during Q4 2022
  • In the last 4 years, Research Frontiers' Asset Writedowns and Impairment had a median value of $11575.0 in 2020 and averaged $36917.0.
  • In the last 5 years, Research Frontiers' Asset Writedowns and Impairment crashed by 7898.77% in 2020 and then skyrocketed by 210000.0% in 2023.
  • Over the past 4 years, Research Frontiers' Asset Writedowns and Impairment (Quarter) stood at $133969.0 in 2019, then plummeted by 78.99% to $28150.0 in 2020, then tumbled by 135.52% to -$10000.0 in 2022, then surged by 1100.0% to $100000.0 in 2023.
  • Its Asset Writedowns and Impairment stands at $100000.0 for Q3 2023, versus -$5000.0 for Q1 2023 and -$10000.0 for Q4 2022.